You are here

TOPIC 313 PHASE I; RNAI CANCER THERAPEUTICS USING NANOTECHNOLOGY; HHSN2612013000

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 261201300030C-7-0-1
Agency Tracking Number: N44CO130030
Amount: $1,000,000.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 2014
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
3180 HIGH POINT DR
CHASKA, MN 55318-9476
United States
DUNS: N/A
HUBZone Owned: Unavailable
Woman Owned: Unavailable
Socially and Economically Disadvantaged: Unavailable
Principal Investigator
 GRETCHEN UNGER
 (952) 443-3798
 GMU@GENESEGUES.COM
Business Contact
 GRETCHEN UNGER
Phone: (952) 443-3798
Email: GMU@GENESEGUES.COM
Research Institution
N/A
Abstract

The design, fabrication, characterization, and preclinical evaluation of novel nanoparticle-based drug formulations capable of delivering candidate RNAi therapeutics for the treatment of cancer.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government